Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment

被引：0
|
作者：
Salim, Amira [1 ]
Najjar, Atia [1 ]
Ahmed, Zubair [1 ]
Mata, Ignacio [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203826
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6-12.011
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
    Tso, Amy R.
    Goadsby, Peter J.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2017, 19 (08)
  • [22] Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine
    Iannone, Luigi Francesco
    De Cesaris, Francesco
    Ferrari, Anita
    Benemei, Silvia
    Fattori, Davide
    Chiarugi, Alberto
    CEPHALALGIA, 2022, 42 (13) : 1323 - 1330
  • [23] Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis
    Vikelis, Michail
    Rikos, Dimitrios
    Argyriou, Andreas A.
    Dermitzakis, Emmanouil V.
    Andreou, Anna P.
    Russo, Antonio
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2025,
  • [24] Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine
    Yang, Seonkyeong
    Orlova, Yulia
    Park, Haesuk
    Smith, Steven M.
    Guo, Yi
    Chapin, Benjamin A.
    Wilson, Debbie L.
    Lo-Ciganic, Wei-Hsuan
    JAMA NEUROLOGY, 2025, 82 (02) : 132 - 141
  • [25] Efficacy and Safety of Anti-CGRP Monoclonal Antibodies in Prevention of Chronic Migraine: A Bayesian Network Meta-analysis
    Haridas, Mundot Puliappadamb
    Tripathy, Amruta
    Maiti, Rituparna
    Srinivasan, Anand
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2024, 22 (01) : 23 - 32
  • [26] Eptinezumab Anti-CGRP monoclonal antibody Treatment of migraine
    Lu, Lingyun
    Liu, Meijun
    Hu, Songshan
    Liu, Yao
    Yang, Dongdong
    Hong, Peiwei
    DRUGS OF THE FUTURE, 2017, 42 (10) : 609 - 615
  • [27] Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients
    Schweiger, Vittorio
    Bellamoli, Paola
    Taus, Francesco
    Gottin, Leonardo
    Martini, Alvise
    Nizzero, Marta
    Bonora, Eleonora
    Del Balzo, Giovanna
    Donadello, Katia
    Secchettin, Erica
    Finco, Gabriele
    De Santis, Daniele
    Polati, Enrico
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
  • [28] DO MULTIPLE TREATMENT CYCLES WITH ANTI-CGRP MONOCLONAL ANTIBODIES MODIFY MIGRAINE COURSE?
    Aurilia, C.
    Egeo, G.
    Proietti, S.
    Torelli, P.
    Cevoli, S.
    D'Onofrio, F.
    Bonassi, S.
    Barbanti, P.
    HEADACHE, 2023, 63 : 126 - 126
  • [29] Anti-CGRP Monoclonal Antibodies for the Treatment of Migraine with Aura: a prospective observational cohort study
    Braca, S.
    Russo, C.
    Miele, A.
    Stornaiuolo, A.
    Sansone, M.
    De Simone, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 376 - 376
  • [30] Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date
    Pellesi, Lanfranco
    Guerzoni, Simona
    Pini, Luigi Alberto
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (06): : 534 - 547
12345